FOXO3 and cancer: Similarly, in leukemia patients FoxO3a phospho-status correlates with some clinical features, such as the percentage of bone marrow (BM) blasts, absolute peripheral blood-(PB) and white blood cells-(WBCs) count, primary resistance, early relapse, and overall survival [34], thus suggesting a pivotal role of FoxO proteins in cancer cells.